SVRA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.33%

Insider Buying (Last 12 Months): $178,179.00

Insider Selling (Last 12 Months): $181,063.62

Savara Insider Trading History Chart

Savara Share Price & Price History

^$2.58

▲ +0.03 (1.18%)

As of 07/25/2025 05:00 PM ET

Days: 30 | 90 | 365

Savara Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/20/2025	Richard J. Hawkins	Director	Buy	48,225	$2.04	$98,379.00	115,466
5/29/2025	Joseph S Mccracken	Director	Buy	10,000	$2.08	$20,800.00	260,837
12/16/2024	Matthew Pauls	CEO	Sell	54,702	$3.31	$181,063.62	1,536,379
11/19/2024	Joseph S Mccracken	Director	Buy	20,000	$2.95	$59,000.00	210,837
12/28/2023	David L Lowrance	CFO	Sell	10,000	$4.71	$47,100.00	342,355
12/28/2023	Matthew Pauls	CEO	Sell	84,000	$4.71	$395,640.00	1,302,674
12/28/2023	Nevan C Elam	Director	Sell	93,843	$4.71	$442,000.53	22,500
7/17/2023	Rick Yang	Major Shareholder	Buy	333,333	$3.00	$999,999.00	24,471,264
6/26/2023	Raymond Dennis Pratt	Insider	Buy	6,500	$2.93	$19,045.00	160,000
5/26/2023	David A. Ramsay	Director	Buy	37,124	$2.63	$97,636.12	2,201,142
5/24/2023	David A. Ramsay	Director	Buy	50,000	$2.56	$128,000.00	2,151,142
12/28/2022	David A. Ramsay	Director	Buy	3,293	$1.50	$4,939.50	2,065,142
12/22/2022	David A. Ramsay	Director	Buy	41,414	$1.48	$61,292.72	2,046,142
12/22/2022	Raymond Dennis Pratt	Insider	Buy	3,500	$1.54	$5,390.00	153,500
12/19/2022	David A. Ramsay	Director	Buy	40,719	$1.49	$60,671.31	1,987,312
12/16/2022	David A. Ramsay	Director	Buy	341	$1.50	$511.50	1,946,593
11/23/2022	David A. Ramsay	Director	Buy	4,610	$1.44	$6,638.40	1,946,252
11/21/2022	David A. Ramsay	Director	Buy	25,005	$1.42	$35,507.10	1,926,147
11/17/2022	David A. Ramsay	Director	Buy	8,900	$1.27	$11,303.00	1,885,042
9/26/2022	David A. Ramsay	Director	Buy	31,107	$1.38	$42,927.66	1,802,249
9/23/2022	David A. Ramsay	Director	Buy	30,000	$1.42	$42,600.00	1,771,142
9/19/2022	David A. Ramsay	Director	Buy	1,400	$1.46	$2,044.00	1,740,542
9/16/2022	David A. Ramsay	Director	Buy	6,000	$1.44	$8,640.00	1,739,142

See Full Table

SEC Filings (Institutional Ownership Changes) for Savara (NASDAQ:SVRA)

87.93% of Savara stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Savara Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/11/2025	Farther Finance Advisors LLC	38,001	$87K	0.0%	+17.6%	0.022%
6/27/2025	Goldman Sachs Group Inc.	467,547	$1.30M	0.0%	-29.8%	0.271%
5/29/2025	Rhumbline Advisers	153,542	$0.43M	0.0%	+8.6%	0.089%
5/16/2025	Woodline Partners LP	251,912	$0.70M	0.0%	-90.6%	0.146%
5/16/2025	Exome Asset Management LLC	836,397	$2.32M	2.0%	+19.5%	0.484%
5/16/2025	Goldman Sachs Group Inc.	467,547	$1.30M	0.0%	-29.8%	0.271%
5/16/2025	Bain Capital Life Sciences Investors LLC	17,600,621	$48.75M	7.2%	+20.8%	10.189%
5/16/2025	ADAR1 Capital Management LLC	1,360,291	$3.77M	0.7%	+37.6%	0.787%
5/15/2025	Vestal Point Capital LP	11,000,000	$30.47M	2.2%	+2.1%	6.368%
5/15/2025	Frazier Life Sciences Management L.P.	11,462,301	$31.75M	1.5%	+32.4%	6.635%
5/15/2025	Nantahala Capital Management LLC	8,075,375	$22.37M	0.9%	+7.3%	4.675%
5/14/2025	MetLife Investment Management LLC	52,102	$0.14M	0.0%	-11.8%	0.030%
5/14/2025	Stonepine Capital Management LLC	29,079	$81K	0.1%	N/A	0.017%
5/14/2025	Walleye Capital LLC	207,299	$0.57M	0.0%	N/A	0.120%
5/14/2025	Jump Financial LLC	65,200	$0.18M	0.0%	+214.1%	0.038%
5/14/2025	EntryPoint Capital LLC	181,655	$0.50M	0.2%	+75.9%	0.105%
5/14/2025	Wellington Management Group LLP	4,162,653	$11.53M	0.0%	-24.1%	2.410%
5/13/2025	Brooklyn Investment Group	23,611	$65K	0.0%	N/A	0.014%
5/12/2025	Nuveen LLC	385,103	$1.07M	0.0%	N/A	0.223%
5/12/2025	Invesco Ltd.	89,258	$0.25M	0.0%	+82.9%	0.052%
5/12/2025	Connor Clark & Lunn Investment Management Ltd.	778,954	$2.16M	0.0%	-7.0%	0.451%
5/9/2025	Deutsche Bank AG	916,017	$2.54M	0.0%	-1.2%	0.530%
5/9/2025	Charles Schwab Investment Management Inc.	954,830	$2.65M	0.0%	-0.9%	0.553%
5/9/2025	Vanguard Group Inc.	8,119,247	$22.49M	0.0%	-2.3%	4.700%
5/7/2025	Zurcher Kantonalbank Zurich Cantonalbank	60,343	$0.17M	0.0%	-5.1%	0.035%
5/6/2025	Readystate Asset Management LP	522,791	$1.45M	0.0%	-1.4%	0.303%
5/6/2025	Universal Beteiligungs und Servicegesellschaft mbH	137,694	$0.38M	0.0%	N/A	0.080%
5/6/2025	Y Intercept Hong Kong Ltd	26,661	$74K	0.0%	N/A	0.015%
5/1/2025	Emerald Advisers LLC	3,090,213	$8.56M	0.4%	+32.5%	1.790%
5/1/2025	Emerald Mutual Fund Advisers Trust	2,014,456	$5.58M	0.4%	+46.4%	1.167%
4/30/2025	Alps Advisors Inc.	115,752	$0.32M	0.0%	-16.6%	0.067%
4/29/2025	Bank of New York Mellon Corp	262,935	$0.73M	0.0%	+3.7%	0.152%
4/14/2025	Farther Finance Advisors LLC	32,314	$92K	0.0%	+25.3%	0.019%
4/8/2025	Rhumbline Advisers	153,542	$0.43M	0.0%	+8.6%	0.089%
3/24/2025	Wellington Management Group LLP	5,481,654	$16.83M	0.0%	-36.4%	3.194%
3/18/2025	California State Teachers Retirement System	86,465	$0.27M	0.0%	-8.6%	0.050%
2/18/2025	Frazier Life Sciences Management L.P.	8,660,379	$26.59M	1.1%	+6.2%	5.046%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	156,983	$0.48M	0.0%	+24.8%	0.091%
2/17/2025	Woodline Partners LP	2,686,938	$8.25M	0.1%	+16.6%	1.566%
2/17/2025	Vestal Point Capital LP	10,775,000	$33.08M	2.0%	+33.2%	6.278%
2/17/2025	Squarepoint Ops LLC	122,635	$0.38M	0.0%	+178.1%	0.071%
2/17/2025	Two Sigma Advisers LP	390,715	$1.20M	0.0%	+34.8%	0.228%
2/17/2025	Two Sigma Investments LP	785,477	$2.41M	0.0%	+19.4%	0.458%
2/17/2025	Sphera Funds Management LTD.	1,211,533	$3.72M	0.7%	+115.2%	0.706%
2/17/2025	Rafferty Asset Management LLC	146,997	$0.45M	0.0%	-12.6%	0.086%
2/17/2025	Point72 Asset Management L.P.	700,987	$2.15M	0.0%	N/A	0.408%
2/17/2025	ProShare Advisors LLC	40,627	$0.13M	0.0%	+28.8%	0.024%
2/17/2025	Nuveen Asset Management LLC	384,779	$1.18M	0.0%	-7.4%	0.224%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	48,482	$0.15M	0.0%	+26.0%	0.028%
2/17/2025	Millennium Management LLC	482,263	$1.48M	0.0%	+71.8%	0.281%
2/17/2025	Janus Henderson Group PLC	42,400	$0.13M	0.0%	-82.8%	0.025%
2/17/2025	Farallon Capital Management LLC	6,835,000	$20.98M	0.1%	+49.9%	3.983%
2/17/2025	D. E. Shaw & Co. Inc.	70,560	$0.22M	0.0%	+314.7%	0.041%
2/17/2025	Deutsche Bank AG	927,595	$2.85M	0.0%	+6.1%	0.540%
2/17/2025	Deerfield Management Company L.P. Series C	7,964,000	$24.45M	0.5%	+23.2%	4.640%
2/17/2025	Cubist Systematic Strategies LLC	103,099	$0.32M	0.0%	+91.3%	0.060%
2/17/2025	Bank of America Corp DE	254,253	$0.78M	0.0%	-10.2%	0.148%
2/17/2025	BNP Paribas Financial Markets	99,959	$0.31M	0.0%	+289.1%	0.058%
2/17/2025	Ameriprise Financial Inc.	12,139	$37K	0.0%	N/A	0.007%
2/17/2025	Algert Global LLC	132,968	$0.41M	0.0%	+7.3%	0.077%
2/14/2025	Jane Street Group LLC	35,046	$0.11M	0.0%	-46.0%	0.020%
2/14/2025	Emerald Mutual Fund Advisers Trust	1,375,888	$4.22M	0.3%	N/A	0.802%
2/14/2025	Nantahala Capital Management LLC	7,525,259	$23.10M	1.0%	+45.2%	4.385%
2/14/2025	Northern Trust Corp	1,077,363	$3.31M	0.0%	+9.1%	0.628%
2/14/2025	Susquehanna Fundamental Investments LLC	228,536	$0.70M	0.0%	N/A	0.133%
2/14/2025	Adage Capital Partners GP L.L.C.	2,115,771	$6.50M	0.0%	-68.7%	1.233%
2/14/2025	Price T Rowe Associates Inc. MD	43,668	$0.14M	0.0%	+13.6%	0.025%
2/14/2025	Hsbc Holdings PLC	15,627	$48K	0.0%	N/A	0.009%
2/14/2025	MetLife Investment Management LLC	59,049	$0.18M	0.0%	-11.7%	0.034%
2/14/2025	Dimensional Fund Advisors LP	143,661	$0.44M	0.0%	+3.9%	0.084%
2/14/2025	Altium Capital Management LLC	1,579,000	$4.85M	1.4%	+0.3%	0.920%
2/13/2025	Marshall Wace LLP	361,229	$1.11M	0.0%	N/A	0.210%
2/13/2025	Affinity Asset Advisors LLC	410,586	$1.26M	0.2%	-41.3%	0.239%
2/13/2025	Jump Financial LLC	20,755	$64K	0.0%	N/A	0.012%
2/13/2025	XTX Topco Ltd	11,136	$34K	0.0%	N/A	0.006%
2/13/2025	Barclays PLC	236,705	$0.73M	0.0%	+2.5%	0.138%
2/13/2025	F M Investments LLC	81,343	$0.25M	0.0%	N/A	0.047%
2/13/2025	Raymond James Financial Inc.	259,798	$0.80M	0.0%	N/A	0.151%
2/13/2025	Legal & General Group Plc	95,577	$0.29M	0.0%	-11.7%	0.056%
2/13/2025	ADAR1 Capital Management LLC	988,468	$3.04M	0.6%	+33.1%	0.576%
2/13/2025	Wells Fargo & Company MN	59,277	$0.18M	0.0%	+42.9%	0.035%
2/12/2025	Geode Capital Management LLC	2,784,037	$8.55M	0.0%	+2.1%	1.622%
2/12/2025	Wellington Management Group LLP	5,481,654	$16.83M	0.0%	-36.4%	3.194%
2/12/2025	JPMorgan Chase & Co.	1,423,139	$4.37M	0.0%	+1,948.0%	0.829%
2/11/2025	EntryPoint Capital LLC	103,288	$0.32M	0.1%	+152.1%	0.060%
2/11/2025	Corebridge Financial Inc.	57,367	$0.18M	0.0%	-7.0%	0.033%
2/11/2025	Emerald Advisers LLC	2,332,680	$7.16M	0.3%	N/A	1.359%
2/11/2025	Vanguard Group Inc.	8,309,970	$25.51M	0.0%	+4.6%	4.842%
2/11/2025	KLP Kapitalforvaltning AS	13,200	$41K	0.0%	N/A	0.008%
2/11/2025	Rosalind Advisors Inc.	2,654,944	$8.15M	4.0%	N/A	1.547%
2/10/2025	Cibc World Markets Corp	10,798	$33K	0.0%	N/A	0.006%
2/10/2025	Swiss National Bank	178,000	$0.55M	0.0%	-6.7%	0.104%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	837,467	$2.57M	0.0%	+21.3%	0.488%
2/6/2025	Raymond James Financial Inc.	259,798	$0.80M	0.0%	N/A	0.151%
2/6/2025	Victory Capital Management Inc.	11,246	$35K	0.0%	-92.0%	0.007%
2/6/2025	Charles Schwab Investment Management Inc.	963,821	$2.96M	0.0%	+5.7%	0.562%
2/5/2025	Oppenheimer & Co. Inc.	15,600	$48K	0.0%	-86.5%	0.009%
2/4/2025	Bank of New York Mellon Corp	253,630	$0.78M	0.0%	+7.6%	0.148%
1/30/2025	Rhumbline Advisers	141,425	$0.43M	0.0%	+6.8%	0.082%
1/24/2025	China Universal Asset Management Co. Ltd.	36,390	$0.11M	0.0%	+14.9%	0.021%

Data available starting January 2016

See Full Table

Savara Inc., formerly Mast Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Its pipeline includes AeroVanc, Molgradex and AIR001. AeroVanc is an inhaled formulation of vancomycin, which the Company is developing for the treatment of persistent methicillin-resistant Staphylococcus aureus, lung infection in cystic fibrosis patients. Molgradex is an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor. It is developing Molgradex for the treatment of autoimmune pulmonary alveolar proteinosis, a rare lung disease. AIR001 is a sodium nitrite solution for inhalation via nebulization. AIR001 is in Phase II clinical development for the treatment of heart failure with preserved ejection fraction, also known as diastolic heart failure or heart failure with preserved systolic function.

Today's Range

Now: $2.58

$2.50

$2.63

50 Day Range

MA: $2.36

$1.94

$3.13

52 Week Range

Now: $2.58

$1.89

$4.74

Volume

735,752 shs

Average Volume

1,232,206 shs

Market Capitalization

$445.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.31

Who are the company insiders with the largest holdings of Savara?: Savara's top insider shareholders include:
Matthew Pauls (CEO)
David L Lowrance (CFO)
Joseph S Mccracken (Director)
Richard J Hawkins (Director)
Nevan C Elam (Director)
Learn More about top insider investors at Savara.
Who are the major institutional investors of Savara?: Savara's top institutional investors include:
Farther Finance Advisors LLC — 0.02%
Learn More about top institutional investors of Savara stock.
Which major investors are buying Savara stock?: During the last quarter, SVRA stock was acquired by institutional investors including:
Farther Finance Advisors LLC
During the previous year, these company insiders have bought Savara stock:
Matthew Pauls (CEO)
David L Lowrance (CFO)
Learn More investors buying Savara stock.